The efficacy and safety of subcutaneous immunotherapy in mite-sensitized subjects with asthma: a meta-analysis.

Subcutaneous immunotherapy (SCIT) is widely used in the management of allergic diseases such as allergic asthma. We aimed to conduct a systematic review and meta-analysis to evaluate the efficacy and safety of SCIT in mite-sensitized subjects with asthma.